CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 500 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01086215
NCT01086215N/ACompleted
CompareCT.gov

PEARL II: PEripheral Use of AngioJet® Rheolytic Thrombectomy With a Variety of Catheter Lengths

Boston Scientific Corporation·observational·Posted Mar 15, 2010·Updated Nov 10, 2014

In Brief

An observational study for Peripheral Vascular Disease and 2 related conditions. Completed, enrolled 500 participants across 36 sites in 5 countries.

Detailed Summary

The Registry involves the collection of information for research and educational purposes only on the use of AngioJet in the peripheral vascular system.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsPeripheral Vascular Disease, Embolism and Thrombosis, Venous Thrombosis
CountriesCanada, Germany, Italy, Slovakia, United States
Collaborators--

Timeline

N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedMar 15, 2010
Enrollment StartJan 1, 2010
Primary CompletionJul 1, 2013
Study CompletionSep 1, 2013
TodayJul 2, 2026
Enrollment to primary: 3.5 yearsPosted 16.3 years ago